moday - sunday
8.00 am - 9.00 pm
Jozicular Oncology’s goal is to eradicate cancer by developing personalized immunotherapies to fight multiple cancer types. Our approach focuses on optio debitis the individual nature.
These antigens, called tumor-specific neoantigens, offer attractive therapeutic targets because they are non-self and tumor-specific, and are key targets for a potent immune labore non nobi response.
Lorem ipsum dolor sit, amet consectetur adipisicing elit. Molestias, odio modi earum repellat soluta adipisci neque architecto ex temporibus commodi nesciunt quod labore non nobis, deserunt eaque provident! Quam labore nulla exercitationem asperiores sint, quia consectetur earum debitis quasi.
Dolor sit amet consectetur adipisicing elit. Inventore labore dicta dignissimos optio iure, quod perspiciatis quaerat. Distinctio doloremque expedita, tempora modi molestiae nostrum, ea illum est rerum quam unde!
Executive Vice President and Chief Business Officer
Executive Vice President and Chief Business Officer
Executive Vice President and Chief Business Officer
Executive Vice President and Chief Business Officer
Executive Vice President and Chief Business Officer
Executive Vice President and Chief Business Officer
Jozicular Oncology’s scientific founders published an important discovery in immuno-oncology: in patients with solid tumors who respond to checkpoint inhibitors, mutations in the tumor’s DNA produce critical new targets. These targets, called tumor-specific neoantigens.
Jozicular Oncology’s scientific founders published an important discovery in immuno-oncology: in patients with solid tumors who respond to checkpoint inhibitors, mutations in the tumor’s DNA produce critical new targets.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Molestiae alias quasi aliquid facilis, quisquam non harum nesciunt beatae porro vel tempore accusantium illo accusamus sit commodi saepe exercitationem, recusandae itaque libero vitae architecto voluptates blanditiis ad vero! Vitae, quod sunt? Veritatis temporibus in reiciendis animi, laudantium ab culpa dicta officia.
Ncidunt laboriosam unde modi eligendi fugiat itaque corporis quod autem at laudantium, sapiente impedit doloremque mollitia fuga? Animi doloremque magnam hic. Nulla, sed. In ex officia eligendi necessitatibus, a dolore minus unde? Veritatis aliquid exercitationem aliquam sequi molestias earum quae aut.
XCART Platform
PolyXen™
XBIO-101 (sodium cridanimod)
Collins Street West 8007,
San Fransico, United States.
emample@example.com
emample@example.com
+098 769 023
+098 769 024
Sign in with
google
